药品注册申请号:050759
申请类型:NDA (新药申请)
申请人:ROCHE PALO
申请人全名:ROCHE PALO ALTO LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CELLCEPT MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Yes Yes AB 1998/10/01 1998/10/01 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/08/10 SUPPL-55(补充) Approval Labeling STANDARD
2022/06/06 SUPPL-56(补充) Approval Efficacy STANDARD
2022/06/06 SUPPL-54(补充) Approval Efficacy STANDARD
2021/10/22 SUPPL-51(补充) Approval Labeling STANDARD
2021/10/22 SUPPL-50(补充) Approval Labeling STANDARD
2021/08/11 SUPPL-53(补充) Approval REMS N/A
2021/04/21 SUPPL-52(补充) Approval REMS N/A
2021/01/15 SUPPL-49(补充) Approval REMS N/A
2019/12/13 SUPPL-45(补充) Approval Labeling STANDARD
2019/02/27 SUPPL-43(补充) Approval Labeling STANDARD
2018/08/23 SUPPL-41(补充) Approval Labeling STANDARD
2017/12/18 SUPPL-42(补充) Approval Labeling STANDARD
2015/11/13 SUPPL-40(补充) Approval REMS N/A
2015/07/16 SUPPL-39(补充) Approval Manufacturing (CMC) STANDARD
2015/07/09 SUPPL-38(补充) Approval Labeling STANDARD
2013/09/27 SUPPL-37(补充) Approval REMS N/A
2013/09/27 SUPPL-36(补充) Approval Labeling STANDARD
2013/07/24 SUPPL-34(补充) Approval Manufacturing (CMC) STANDARD
2013/02/14 SUPPL-32(补充) Approval Manufacturing (CMC) STANDARD
2012/09/25 SUPPL-25(补充) Approval Labeling STANDARD
2012/06/22 SUPPL-33(补充) Approval Labeling STANDARD
2012/06/08 SUPPL-31(补充) Approval Labeling STANDARD
2009/10/08 SUPPL-28(补充) Approval Labeling UNKNOWN
2009/06/18 SUPPL-24(补充) Approval Labeling STANDARD
2009/02/27 SUPPL-23(补充) Approval Labeling STANDARD
2008/12/15 SUPPL-22(补充) Approval Labeling STANDARD
2008/05/09 SUPPL-21(补充) Approval Labeling STANDARD
2007/12/20 SUPPL-18(补充) Approval Labeling STANDARD
2007/09/21 SUPPL-19(补充) Approval Labeling STANDARD
2005/10/17 SUPPL-15(补充) Approval Labeling STANDARD
2003/02/28 SUPPL-8(补充) Approval Labeling STANDARD
2002/12/17 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
2001/11/21 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
2001/10/03 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
2001/02/01 SUPPL-7(补充) Approval Manufacturing (CMC) STANDARD
2000/12/20 SUPPL-5(补充) Approval Efficacy STANDARD
2000/07/28 SUPPL-6(补充) Approval Efficacy STANDARD
2000/07/27 SUPPL-4(补充) Approval Labeling STANDARD
2000/06/16 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
2000/04/20 SUPPL-2(补充) Approval Manufacturing (CMC) STANDARD
1999/06/11 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1998/10/01 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
001 4753935 2009/05/03 Y Y PDF格式**本条是由Drugfuture回溯的历史信息**
5688529 2014/11/18 Y PDF格式**本条是由Drugfuture回溯的历史信息**
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:MYCOPHENOLATE MOFETIL 剂型/给药途径:FOR SUSPENSION;ORAL 规格:200MG/ML 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
050759 001 NDA CELLCEPT MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Prescription Yes Yes AB 1998/10/01 ROCHE PALO
203005 001 ANDA MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Prescription No No AB 2014/11/14 ALKEM LABS LTD
210370 001 ANDA MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Prescription No No AB 2019/02/12 VISTAPHARM
214525 001 ANDA MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Prescription No No AB 2021/07/29 LANNETT CO INC
214871 001 ANDA MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Prescription No No AB 2021/11/02 AMNEAL
211272 001 ANDA MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Prescription No No AB 2022/01/25 TEVA PHARMS USA
212634 001 ANDA MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Prescription No No AB 2023/08/29 STRIDES PHARMA
213955 001 ANDA MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL FOR SUSPENSION;ORAL 200MG/ML Prescription No No AB 2023/09/11 HETERO LABS LTD V
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database